Synovis Life Technologies, Inc. (NASDAQ:SYNO)
Industry: Healthcare

OFF LIST - 1956 consecutive market days: OFF LIST as of 08/27/2008 Through 11/14/2016

Synovis Life Technologies, Inc., a medical device company, develops, manufactures, and markets mechanical and biological products used by surgical specialties for the repair of soft tissue damaged or destroyed by disease or injury. Its products include implantable biomaterials for soft tissue repair, devices for microsurgery, and surgical tools. The companys biomaterial products include Peri-Strips that are biomaterial stapling buttress used as reinforcement at the surgical staple line; Veritas for use in surgery to repair soft tissue; Tissue-Guard, which is used to repair and replace damaged tissue in cardiac, vascular, thoracic, and neurologic procedures; and Ortho & Wound products for the treatment of chronic wounds, as well as for use in orthopedic applications. Its devices for microsurgery comprise Microvascular Anastomotic Coupler, which enables micro surgeons in various surgical specialties to perform anastomotic microsurgical procedures; GEM Microclip, a hemostatic clip designed to securely ligate vessels and provide for atraumatic occlusion; and Neurotube, a device designed to assist in the reconnection of severed nerves. The company also distributes microsurgery product lines for companies. Synovis Life Technologies sells its products through direct sales force and independent distributors primarily in the United States, Europe, Canada, and the Asia Pacific region. The company was formerly known as Bio-Vascular, Inc. Synovis Life Technologies was founded in 1985 and is headquartered in St. Paul, Minnesota.

Current Quote*
Last: $Unk
Change: 0.000
Book: $3.300
Volume: Unk

As Of: 08/30 13:17 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol SYNO

  • No BuyIns.Net Alerts Available for SYNO

Graphs for SYNO


3 Month Graph


6 Month Graph


1 Year Graph